Cargando…
Quantification of Biologically Active DNA Alkylation in Temozolomide-Exposed Glioblastoma Cell Lines by Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry: Method Development and Recommendations for Validation
[Image: see text] Quantitative monitoring of biologically active methylations of guanines in samples exposed to temozolomide (TMZ) would be useful in glioblastoma research for preclinical TMZ experiments, for clinical pharmacology questions regarding appropriate exposure, and ultimately for precisio...
Autores principales: | Fresnais, Margaux, Jung, Ina, Klein, Uli B., Theile, Dirk, Liang, Siwen, Haefeli, Walter E., Burhenne, Jürgen, Longuespée, Rémi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324051/ https://www.ncbi.nlm.nih.gov/pubmed/37426236 http://dx.doi.org/10.1021/acsomega.3c01818 |
Ejemplares similares
-
Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA
por: Fresnais, Margaux, et al.
Publicado: (2023) -
Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma
por: Fresnais, Margaux, et al.
Publicado: (2021) -
Desorption Kinetics Evaluation for the Development of Validated Desorption Electrospray Ionization-Mass Spectrometric Assays for Drug Quantification in Tissue Sections
por: Fresnais, Margaux, et al.
Publicado: (2023) -
Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay
por: Fresnais, Margaux, et al.
Publicado: (2020) -
Development and Validation of an LC–MS-Based
Quantification Assay for New Therapeutic Antibodies: Application to
a Novel Therapy against Herpes Simplex Virus
por: Fresnais, Margaux, et al.
Publicado: (2020)